A new compound C₁₇H₂₀FN₃O₃²⁺·CuBr₄²⁻·H₂O is synthesized in the crystal form, where C₁₇H₁₈FN₃O₃ (CfH, ciprofloxacin) is 4-oxo-7-(1-piperazinyl)-6-fluoro-1-cyclopropyl-1,4-dihydroquinoline-3-carboxylic acid. Crystallographic data of ciprofloxacinium tetrabromocuprate(II) monohydrate, C₁₇H₂₂Br₄CuFN₃O₄: a = 8.214(1) ?, b = 10.781(2) ?, c = 13.703(2) ?, α = 85.144(2)°, β = 79.119(2)°, γ = 84.018(2)°, V = 1182.5(4) ?³, P [`1]bar 1 space group, Z = 2. Supramolecular architecture of the crystal differs from that established for C₁₇H₂₀FN₃O₃²⁺·CuCl₄²⁻·H₂O by the absence of π-π interactions of the aromatic rings of CfH₃²⁺ ions and also the structural motifs formed by intermolecular hydrogen bonds.